SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-049289
Filing Date
2020-02-26
Accepted
2020-02-26 08:50:50
Documents
14
Period of Report
2020-02-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d896859d8k.htm   iXBRL 8-K 27839
2 EX-99.1 d896859dex991.htm EX-99.1 43961
6 GRAPHIC g896859g0226021857500.jpg GRAPHIC 3482
  Complete submission text file 0001193125-20-049289.txt   212294

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mdgl-20200226.xsd EX-101.SCH 3087
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdgl-20200226_lab.xml EX-101.LAB 18907
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdgl-20200226_pre.xml EX-101.PRE 11874
9 EXTRACTED XBRL INSTANCE DOCUMENT d896859d8k_htm.xml XML 3543
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 20653411
SIC: 2834 Pharmaceutical Preparations